Medigen Biotechnology (ROCO:3176) Revenue : NT$1,158 Mil (TTM As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Medigen Biotechnology Revenue?

Medigen Biotechnology's revenue for the three months ended in Dec. 2023 was NT$371 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was NT$1,158 Mil. Medigen Biotechnology's Revenue per Share for the three months ended in Dec. 2023 was NT$2.65. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$8.32.

Warning Sign:

Medigen Biotechnology Corp revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Medigen Biotechnology was 9.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 23.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 29.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was 26.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Medigen Biotechnology's highest 3-Year average Revenue per Share Growth Rate was 357.90% per year. The lowest was -42.10% per year. And the median was 12.80% per year.

Medigen Biotechnology Revenue Historical Data

The historical data trend for Medigen Biotechnology's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medigen Biotechnology Revenue Chart

Medigen Biotechnology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Revenue

Get a 7-Day Free Trial

552.35

615.54

3,922.01

1,055.95

1,157.72

Medigen Biotechnology Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Revenue	Get a 7-Day Free Trial															203.71	164.25	205.57	416.88	371.03

Competitive Comparison of Medigen Biotechnology's Revenue

For the Biotechnology subindustry, Medigen Biotechnology's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medigen Biotechnology's Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medigen Biotechnology's Revenue distribution charts can be found below:

* The bar in red indicates where Medigen Biotechnology's Revenue falls into.

Medigen Biotechnology Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1,158 Mil.

Medigen Biotechnology (ROCO:3176) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Medigen Biotechnology Revenue Related Terms

Thank you for viewing the detailed overview of Medigen Biotechnology's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Medigen Biotechnology (ROCO:3176) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigen Biotechnology Corp (ROCO:3176) » Definitions » Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Yuancyu Street, 14F, Building No.3,, Nangang District, Taipei, TWN, 11560

Website

https://www.medigen.com.tw

Medigen Biotechnology Corp is a biopharmaceutical company primarily engaged in new drug development, drug discovery, molecular diagnostics, vaccine, and generic drugs. The new drug development business focuses mainly on the clinical stage of drug development and includes PI-88 MUPAFOSTAT for the treatment of liver cancer and OBP-301 treatment using adenovirus targeted to cancer cells only. Drug discovery includes the development of human-native mAbs for therapeutic applications related to infectious diseases. Generic drugs include pharmaceuticals for infectious diseases (antibiotics), contraceptives, nutrition milk powder, vitamin C tablets, dermatologic agents, and eye care products.

Medigen Biotechnology (ROCO:3176) Headlines

No Headlines